| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972753 | The Journal of Heart and Lung Transplantation | 2008 | 7 Pages |
Abstract
Our study suggests the long-term advantage of ATG in prevention of cardiac allograft vasculopathy. In contrast, OKT3 failed to show such benefit. However, induction therapy with either ATG or OKT3 did not exhibit a significant beneficial effect on long-term patient survival.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ruoyu MD, Axel MD, PhD, Martin MD, PhD, Andre MD, PhD, Christoph MD,